A splice variant of ADAMTS13 is expressed in human hepatic stellate cells and cancerous tissues

Summary

Although ADAMTS13, the von Willebrand factor (VWF)-cleaving protease, is expressed in a range of tissues, the physiological significance of tissue-specific ADAMTS13 alternative splicing isoforms have yet to be clarified. Screening a panel of human tissues and cell lines revealed a spliced ADAMTS13 transcript in hepatic stellate cells and a hepatoma cell line that retains the 25^th intron. A nonsense codon within the intron truncates the protease, which gains 64 novel amino acids in lieu of both CUB domains. This isoform, while retaining VWF-cleaving capability, accumulates intracellularly and its biological inaccessibility may prevent its participation in regulating haemostasis and other physiologic functions.

Keywords

ADAMTS13 - alternative splicing - intron retention - TTP - CUB domain

^# These authors contributed equally to the research in this manuscript.

• References

• 1 Levy GG, Nichols WC, Lian EC. et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 2001; 413: 488-494.
• 2 Tsai HM. Deficiency of ADAMTS-13 in thrombotic and thrombocytopenic purpura. J Thromb Haemost 2003; 1: 2038-2040.
• 3 Majerus EM, Anderson PJ, Sadler JE. Binding of ADAMTS13 to von Willebrand factor. J Biol Chem 2005; 280: 21773-21778.
• 4 Banno F, Kaminaka K, Soejima K. et al. Identification of strain-specific variants of mouse Adamts13 gene encoding von Willebrand factor-cleaving protease. J Biol Chem 2004; 279: 30896-30903.
• 5 Shang DZ, Zheng XW, Niiya M. et al. Apical sorting of ADAMTS13 in vascular endothelial cells and Madin-Darby canine kidney cells depends on the CUB domains and their association with lipid rafts. Blood 2006; 108: 2207-2215.
• 6 Brennan SO, Homer VM, Davis RL. et al. Hypofibrinogenaemia associated with common gamma 82Ala -> Gly mutation is not mediated by altered mRNA splicing. Thromb Haemost 2006; 96: 535-537.
• 7 Censarek P, Steger G, Paolini C. et al. Alternative splicing of platelet cyclooxygenase-2 mRNA in patients after coronary artery bypass grafting. Thromb Haemost 2007; 98: 1309-1315.
• 8 Zheng XL, Chung D, Takayama TK. et al. Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura. J Biol Chem 2001; 276: 41059-41063.
• 9 Uemura M, Tatsumi K, Matsumoto M. et al. Localization of ADAMTS 13 to the stellate cells of human liver. Blood 2005; 106: 922-924.
• 10 Xu L, Hui AY, Albanis E. et al. Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut 2005; 54: 142-151.
• 11 Geetha S, Allen CE, Hunt RC. et al. Detection of Intracellular ADAMTS13, a Secreted Zinc-Metalloprotease, via Flow Cytometry. Cytometry Part A 2009; 75A: 675-681.
• 12 Sauna ZE, Okunji C, Hunt RC. et al. Characterization of conformation-sensitive antibodies to ADAMTS13, the von Willebrand cleavage protease. Plos One 2009; 4: e6506.
• 13 Yeo G, Burge CB.. Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J Comput Biol 2004; 11: 377-394.
• 14 Ishikawa Y, Wirz J, Vranka JA. et al. Biochemical Characterization of the Prolyl 3-Hydroxylase 1 Cartilage-associated Protein Cyclophilin B Complex. J Biol Chem 2009; 284: 17641-17647.
• 15 Goren A, Ram O, Amit M. et al. Comparative analysis identifies exonic splicing regulatory sequences – The complex definition of enhancers and silencers. Mol Cell 2006; 22: 769-781.
• 16 Pimanda JE, Maekawa A, Wind T. et al. Congenital thrombotic thrombocytopenic purpura in association with a mutation in the second CUB domain of ADAMTS13. Blood 2004; 103: 627-629.
• 17 Kim E, Goren A, Ast G. Insights into the connection between cancer and alternative splicing. Trends Genetics 2008; 24: 7-10.
• 18 Donati MB. Cancer and Thrombosis. Haemostasis 1994; 24: 128-131.